[HTML][HTML] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of vascular …, 2006 - Elsevier
OBJECTIVE: Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
[HTML][HTML] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of Vascular …, 2006 - jvascsurg.org
Objective Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
[引用][C] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. Discussion
TF REHRING, RS STOLCPART… - Journal of vascular …, 2006 - pascal-francis.inist.fr
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial
disease. Discussion CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
disease. Discussion CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
TF Rehring, RS Stolcpart… - Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of Vascular …, 2006 - infona.pl
Our group and others have previously established that patients with peripheral artery
disease (PAD) are significantly undertreated with respect to overall cardiovascular risk factor …
disease (PAD) are significantly undertreated with respect to overall cardiovascular risk factor …
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.
TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of Vascular …, 2006 - europepmc.org
Objective Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
[PDF][PDF] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
JA Merenich, HW Hollis Jr - 2006 - blogs.qu.edu.qa
Objective: Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …